Early dysanapsis in experimental bronchopulmonary dysplasia: implications for lifelong lung disease

Elizabeth A McGinn1,2, Alexander Sosa3, Mary Corrigan2,4

  • 1Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.

Insights

Antenatal endotoxin exposure in rats causes lasting lung development abnormalities and impaired lung function, mimicking bronchopulmonary dysplasia (BPD). This early airway growth disruption leads to long-term obstructive lung disease.

Area of Science:

  • Pulmonary Medicine
  • Developmental Biology
  • Neonatology

Background:

  • Perinatal lung development disruptions can cause bronchopulmonary dysplasia (BPD), characterized by impaired alveolar, vascular, and airway growth.
  • Antenatal endotoxin (AN-ETX) exposure in rat models mimics chorioamnionitis and causes neonatal dysanapsis, but its long-term effects on lung function are unknown.

Purpose of the Study:

  • To investigate if antenatal endotoxin exposure causes persistent airway and distal lung growth differences in experimental bronchopulmonary dysplasia.
  • To determine the long-term impact of antenatal stress on lung development and function.

Main Methods:

  • Sprague Dawley rats received intra-amniotic AN-ETX on embryonic day 20 (E20), delivered on E22.
  • Pups were assessed on postnatal days 14 (D14) and 28 (D28) using lung morphometry, mechanics testing, and micro-CT for airway and vascular analysis.

Main Results:

  • AN-ETX exposure resulted in persistent growth failure, reduced alveolarization and vascularization, right ventricular hypertrophy, and impaired lung mechanics at D14 and D28.
  • Airway analysis revealed decreased large airway size at D14 and medium airway diameters by D28.
  • Early airflow obstruction (decreased FEV0.1/FVC ratio) at D14 worsened by D28, with decreased FEV0.1.

Conclusions:

  • Adverse antenatal stress alone can induce sustained lung development abnormalities extending beyond the neonatal period.
  • Early dysanapsis, or abnormal airway growth, may predispose to structural obstructive lung disease and lifelong impaired lung function.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...